General Information of the Compound
Compound ID
CP0355671
Compound Name
4-(2-(thiophen-2-yl)-9H-purin-6-yl)morpholine
    Show/Hide
Synonyms
4-(2-(thiophen-2-yl)-9H-purin-6-yl)morpholine
CHEMBL604876
SCHEMBL4439490
    Show/Hide
Structure
Formula
C13H13N5OS
Molecular Weight
287.348
Canonical SMILES
C1CN(CCO1)c1nc(nc2nc[nH]c12)-c1cccs1
    Show/Hide
InChI
InChI=1S/C13H13N5OS/c1-2-9(20-7-1)11-16-12-10(14-8-15-12)13(17-11)18-3-5-19-6-4-18/h1-2,7-8H,3-6H2,(H,14,15,16,17)
    Show/Hide
InChIKey
WKJDCMFOOMWIQG-UHFFFAOYSA-N
Physicochemical Property
logP
1.918
Rotatable Bonds
2
Heavy Atom Count
20
Polar Areas
66.93
Hydrogen Bond Donor Count
1
Hydrogen Bond Acceptor Count
6
Complexity
20

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 25074311
SID: 56412593
ChEMBL ID
CHEMBL604876
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01065, Serine/threonine-protein kinase mTOR
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000006 HEK293 Homo sapiens (Human)  1
1
IC50 = 2800 nM
   TI
   LI
   LO
   TS
Cell Viability or Cytotoxicity Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000034 Caco-2 Homo sapiens (Human)  1
1
IC50 > 10000 nM
   TI
   LI
   LO
   TS
Clinical Information about the Compound
Drug 1 ( 4-(2-(thiophen-2-yl)-9H-purin-6-yl)morpholine )
Drug Name 4-(2-(thiophen-2-yl)-9H-purin-6-yl)morpholine
Target(s)
Serine/threonine-protein kinase mTOR (mTOR)
Inhibitor